ArticleRheumatology (Oxford, England)2022

Autoantibodies against four-and-a-half-LIM domain 1 (FHL1) in inflammatory myopathies: results from an Australian single-centre cohort.

Angeles S Galindo-Feria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.